Isabl

Curated by Signal

Developer of a medical diagnosis platform to analyze genome of cancer patients

Overview

Developer of a medical diagnosis platform to analyze genome of cancer patients. It offers Isabl GxT platform that analyzes the genome and transcriptome to identify mutations, disease surveillance and biomarker discovery.

Key facts

Founded: 2016
Headquarters: New York City, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

2 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Cardiospire
Provider of a non-invasive hemodynamic monitoring of cardiac diseases
Life Sciences TechnologySan Francisco, United States
Altimate
Provider of medical devices for neurological disease, and computational physics
Life Sciences TechnologyBoston, United States
Butterfly Network
Portable ultrasound system for external ultrasound imaging
Life Sciences TechnologyGuilford, United States

About Isabl

What does Isabl do?

Developer of a medical diagnosis platform to analyze genome of cancer patients.

Where is Isabl headquartered?

Isabl is headquartered in New York City, United States.

When was Isabl founded?

Isabl was founded in 2016.

Which sector is Isabl in?

Isabl operates in Life Sciences Technology.

Who are Isabl's competitors?

Companies similar to Isabl include Cardiospire, Altimate, and Butterfly Network.